Circumventing T-cell Tolerance to Tumour Antigens
- 30 September 2001
- journal article
- Published by Elsevier in Biologicals
- Vol. 29 (3-4) , 277-283
- https://doi.org/10.1006/biol.2001.0300
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Low-Avidity Self-Specific T Cells Display a Pronounced Expansion Defect That Can Be Overcome by Altered Peptide LigandsThe Journal of Immunology, 2001
- IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicityNature, 2001
- Changing T cell specificity by retroviral T cell receptor displayProceedings of the National Academy of Sciences, 2000
- Enhanced Antigen-Specific Antitumor Immunity with Altered Peptide Ligands that Stabilize the MHC-Peptide-TCR ComplexImmunity, 2000
- In vitroevolution of a T cell receptor with high affinity for peptide/MHCProceedings of the National Academy of Sciences, 2000
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Tolerance to p53 by A2.1-restricted Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 1997
- Immunobiology of Human Melanoma Antigens MART-1 and gp100 and their Use for Immuno-Gene TherapyInternational Reviews of Immunology, 1997
- Phenotypic Analysis of Antigen-Specific T LymphocytesScience, 1996
- Cytotoxic T cells recognize fragments of the influenza nucleoproteinCell, 1985